Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 98,243Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6MELINTA THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

US Patent Number : 8420592

Drug Substance Claim :

Drug Product Claim :

Application Number : 206334

Patent Use Code : U-1570

Delist Requested :

Patent Use Description : TREATMENT OF BACTERIAL...

Patent Expiration Date : 2029-08-29

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

US Patent Number : 9682061

Drug Substance Claim :

Drug Product Claim :

Application Number : 214155

Patent Use Code : U-3101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-26

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

US Patent Number : 8420592

Drug Substance Claim :

Drug Product Claim :

Application Number : 214155

Patent Use Code : U-3101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-29

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

US Patent Number : 9682061

Drug Substance Claim :

Drug Product Claim :

Application Number : 206334

Patent Use Code : U-1569

Delist Requested :

Patent Use Description : TREATMENT OF BACTERIAL...

Patent Expiration Date : 2030-04-26

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

US Patent Number : 9649352

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214155

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-16

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

US Patent Number : 9649352

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206334

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-16

blank